London Global Cancer Week is convened by a leadership group drawn from across the cancer community. The initiative operates independently, with guidance from advisors and partner organisations committed to advancing global cancer outcomes.

Transparency, collaboration and inclusivity underpin the governance of the Week.

Our Steering Group

Dr Susannah Stanway MBChB MSc FRCP MD | Co-convenor

Dr Susannah Stanway MBChB MSc FRCP MD | Co-convenor

Dr Susannah Stanway is an honorary consultant medical oncologist at the Royal Marsden Hospital in the UK, specializing in breast cancer with an interest in global cancer care and has an associate honorary faculty position at the Institute of Cancer Research (ICR). She is a past president of the Oncology Section of the Royal Society of Medicine where she founded and chaired the steering group of a conference that brought people together to address global cancer outcome disparities, which was held annually between November 2016-2018. She now co-convenes London Global Cancer Week. She teaches about global cancer control on several post-graduate courses in the UK (for example on the Institute of Cancer Research MSc course, UCL Global Health MSc course and The London School of Hygiene and Tropical Medicine on the Diploma of Tropical Medicine and Hygiene course) and speaks nationally and internationally.

She has received three awards from the Global Challenges Research Fund to collaboratively contribute to research projects in sub-Saharan Africa and is on the editorial board of eCancer. She is in the European Cancer Organisation Inequalities Network, has historically been on the European Society of Medical Oncology Global Policy committee and is on the American Society of Clinical Oncology International Affairs Committee. She is a co-founder of the UK and Ireland Global Cancer Network and is part of the Canadian Global Oncology Network. She is currently working with colleagues in several conflict affected, fragile and low-income settings to contribute to capacity building for cancer care. She is interested in the nexus of climate change and health and chairs the international affairs group of Oncology Advocates United for Climate and Health (OUCH).

She has recently studied Public Policy Analysis at the London School of Economics. Alongside an interest in reducing between-country cancer outcome inequalities she has an interest in reducing within-country inequalities in the UK, for example sitting on the Breast Cancer Now Improving Public Health, Equity and Wellbeing Committee. She serves on the Development Board of Breast Cancer Now. She lives in London with her husband and four children.

Dr Katie Wakeham FRCR, PhD

Dr Katie Wakeham FRCR, PhD

As an NHS-trained Clinical Oncology Consultant, she believes that solutions for common global challenges in delivering radiotherapy can be found through international collaboration and partnerships. Her involvement in London Global Cancer Week provides a platform to form alliances aimed at educating, exchanging experiences, advocating, and influencing cancer control policy both in the UK and internationally.

She recently authored a 10-year World-class vision for radiotherapy in the UK, led by the All Party Parliamentary Group for Radiotherapy and launched at the House of Commons in February 2024 (https://radiotherapy.org.uk/radiotherapy-vision/). Additionally, she actively supports the work of the Global Coalition for Radiotherapy to ensure the integration of radiotherapy into cancer plans (https://www.globalradiotherapy.org).

Earlier in her career, she worked in Uganda across various roles. Between 2004 and 2005, she served as a clinician in both a government hospital and with Hospice Africa Uganda, an NGO delivering palliative care in the community. From 2007 to 2013, she was based at the MRC Uganda Unit on AIDS Research, initially as a trials co-ordinator and subsequently as a Wellcome Trust PhD Fellow, investigating cancers and oncogenic infection. From 2021 to 2023, she held the position of Section Head of Radiotherapy at the International Atomic Energy Agency (IAEA), where she developed projects to enhance access to quality radiotherapy in low- and middle-income settings.

She has also led Global Oncology lectures and events at prestigious institutions such as the London School of Hygiene and Tropical Medicine, Royal Society of Medicine, and The Royal College of Radiology. Furthermore, she designed the Medical Training and Fellowship Programme course, delivered by the Royal College of Physicians between 2016 and 2020, aimed at providing training in cancer triage and improving patient referral pathways in Uganda and the wider East African Community.

As a founding member of the UK and Ireland Global Cancer Network and co-chair of the London Global Cancer Week, she continues to play an active role in advancing cancer care on a global scale.

Miriam Mutebi, MD, MMed, MSc, FACS

Miriam Mutebi, MD, MMed, MSc, FACS

Dr. Miriam Mutebi is a Consultant Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the Aga Khan University in Nairobi, Kenya. She is also a clinical epidemiologist and health systems researcher with a research focus on understanding barriers to access for women with cancers in Sub-Saharan Africa and in designing interventions to mitigate those barriers.

 She is the President Elect of the African Organization for Research and Training in Cancer (AORTIC), the Immediate Past President of the Kenya Society of Hematology and Oncology (KESHO) and on the board of directors of the Union for International Cancer Control (UICC).  She is also the co-founder of the Pan African Women’s Association of Surgeons (PAWAS-www.africanwomensurgeons.org) which was developed to mentor and provide transformative leadership for women in surgery in order to improve surgical care and pathology on the continent and is part of the Kenya Association of Women Surgeons.

She is the Co-chair of the National Cancer Taskforce in Kenya, Chair of the Commonwealth Taskforce for the elimination of Cervical Cancer and a commissioner with five Lancet commissions including Women and cancer, Cancer in sub-Saharan Africa and Breast Cancer. She is currently pursuing a pilot’s licence in order to extend breast care services to marginalised areas.

Gevorg Tamamyan, MD, MSc, PhD, DSc, FASCO

Gevorg Tamamyan, MD, MSc, PhD, DSc, FASCO

Gevorg Tamamyan is the Co-Founder and Editor-in-Chief of OncoDaily, the world’s largest oncology media platform, created to democratize access to reliable, independent, and evidence-based cancer information globally. Under his leadership, OncoDaily has evolved into a trusted global reference in oncology and is currently expanding into additional medical disciplines, with a strategic plan to develop up to 50 specialized health channels over the next five years.

Dr. Tamamyan was elected and currently serves as President the International Society of Pediatric Oncology (SIOP) Asia Continental Branch, representing pediatric oncology professionals across Asia, and the Pediatric Oncology East & Mediterranean (POEM) Group, uniting 28 countries and 110 cancer centers. He later became Co-Chair of the St. Jude EURO Regional Advisory Committee, encompassing 13 European countries.

Dr. Tamamyan was the Head of the Pediatric Cancer and Blood Disorders Center of Armenia, where he led the consolidation of previously fragmented pediatric oncology and hematology services into a single national center. Under his leadership, the center evolved into a regional reference point, with survival rates reaching up to 80%. He also co-founded a national pediatric cancer charity ensuring universal coverage for diagnosis and treatment for every child and young adult in Armenia.
Dr. Tamamyan is a Professor and Chairman of Hematology and Pediatric Oncology at Yerevan State Medical University, CEO of the Immune Oncology Research Institute, and adviser to the University’s Rector. He previously served as President of the Harvard Club of Armenia. Educated and trained across seven countries in Europe, North America, and Asia, his professional trajectory spans frontline clinical practice, research, academic leadership, national center executive leadership, global health diplomacy, and institution building.

.

 

Eduardo Cazap MD, PhD, FASCO

Eduardo Cazap MD, PhD, FASCO

Eduardo Cazap is an Argentinean medical oncologist, Founder and first President of the Latin American & Caribbean Society of Medical Oncology (SLACOM), Past- President of the International Union against Cancer (UICC) and Emeritus Professor, Latin-American School of Oncology. Ambassador for the UICC at Summit and World Congress

He published over 200 papers, President of the UICC World Cancer Congress in 2012. He received in 2013 the Distinguished Achievement Award of the Conquer Cancer Foundation (USA) and was bestowed a Fellow of the American Society of Clinical Oncology (FASCO). 2018 Harvard Distinguished Leader Award; Harvard Medical School. Chair of the Global Track- Annual Meeting Education Committee (ASCO), Founding National Cancer Institute of Argentina member.

Editor-in-Chief, Ecancer Medical Science(UK), Co-Editor, Global Health Section, The Oncologist(USA) and Editorial member of around 20 other International peer-reviewed Cancer Journals.

Acting as a promoter of the concept of “ Global Cancer Control “ Dr. Cazap advises, collaborates, or participates with leading cancer international organizations such as OMS, PAHO, UICC, IARC, NCI-US, ASCO,ESMO, AACR, AORTIC,IAEA-PACT, Harvard Global Health Catalyst between others.

Eduardo Cazap has vast in-country and international experience. He is a regular plenary speaker, chair, or moderator at global cancer and health meetings as well as part of organizing major international conferences.

.

 

Dr Liqiang Qi, PhD, MD

Dr Liqiang Qi, PhD, MD

Dr Liqiang Qi is a breast surgical consultant working at Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS),National Cancer Centre, China. He got his PhD degree at UMCG, the Netherlands in 2010.

He is the chairman of Breast Division, the Zhongguancun Strategic Alliance of Technology Innovation for Minimally Invasive Tumor Therapy (ZGCMITT). He is the executive chairman of Breast Health and Breast Feeding Division,Chinese Association for Improving Birth Outcome and Child Development. He is the general director of Popular Science Division, Chinese Medical Doctor Association. He is also the vice president of Beijing Society for the Prevention and Treatment of Gonadal Axis Diseases. He is the editorial board member of Chinese Journal of Minimally Invasive Surgery, China Health Standard Management  and Journal of Multidisciplinary Cancer Management  (electronic version).

Dr Qi is enthusiastic in the promotion and popularization of the cancer knowledge to the public. In recent years, he has participated hundreds of living lectures about breast cancer and has made thousands of short videos on breast cancer prevention and treatment. The total beneficiary is nearly 100 million people. In 2023, he was awarded the “the most beautiful volunteer doctor ”in China.

Prof Chris Jackson

Prof Chris Jackson

Chris Jackson is a medical oncologist and Professor of Oncology at the University of Otago, Dunedin.

 His research and professional interests are in access to better, fairer, more equitable cancer care.

He was previously the medical director of the Cancer Society of NZ, and his advocacy led to the development of a new national cancer plan, and to the birth of the national cancer agency. 

He is a founding member of the Common Sense Oncology movement, served on ASCO’s Asia-Pacific Regional Council, is on the editorial board for the Journal of Global Oncology, and is a member of the programme board of the International Cancer Benchmarking Project (ICBP). He is a member of ASCO, ESMO, Australasian GI Trials group and on the Executive committee of the NZ Society for Oncology.

He is a Radiohead tragic, rugby fan, sideline football dad, and his kids describe him as “one of their favourite parents”.

Dr Olubukola Ayodele | Co-convenor

Dr Olubukola Ayodele | Co-convenor

Dr Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, UK who specializes in the management of breast malignancies. She is an honorary Senior Lecturer at the University of Leicester and the Head of the Breast Cancer Unit at the Leicester Cancer Research Centre, also leading the breast cancer clinical trials portfolio.  She obtained a dual fellowship in drug development and sarcoma from the Princess Margaret Cancer Centre (PMCC) in Toronto, Canada, following specialist oncology training in the Republic of Ireland. She is the inaugural recipient of the ISMO-PMCC collaboration fellowship award in 2018. She is a recipient of the 2021 ASCO Conquer Cancer Endowed Merit award. She is the author of multiple publications including a book chapter and serves as a reviewer for several scientific journals. Dr Ayodele has a portfolio of academic and commercial clinical trials which she runs alongside collaborative translational research projects focusing on molecular drivers and biomarkers in breast cancer. She has received multiple grants for her research work.

Dr Ayodele is passionate about global oncology. She has a postgraduate diploma in Global Health Education from the University of Toronto and is an alumnus of the Global Oncology Leadership Development Program in PMCC in other to facilitate collaboration and advocacy of cancer care in LMICs. She is on the Steering Group of the London Global Cancer Week and organises the Friday in-person meeting. She is an active member of UK & Ireland Global Cancer Network. She is a trustee of the British Nigerian Oncology Group and CupArise charities. She sits on the tumour board of many cancer centres in Nigeria, helping in the management of cancer patients in a multidisciplinary fashion. Dr Ayodele also has interests in reducing inequalities in the UK & Europe. She sits on Breast Cancer Now Inequalities Funding Committee and the European Cancer Organisation (ECO) Inequalities Network contributing to health policies. She has been actively involved in several projects involving breast cancer in black women. She recently launched “The Ebony Experience With Cancer” (TEEWC), a platform for black people who have been affected by cancer with the aim of increasing awareness and educating the public, in order to reduce the poor outcomes in cancer among the black population. She is involved with several charities and NGOs in the UK and Nigeria in organizing educational programs, research and capacity building workshops.

Dr Ayodele is a member of ASCO, ESMO, ACP and UKBCG.

Myrna Abi Abdallah Doumit - Tenured Associate Professor

Myrna Abi Abdallah Doumit - Tenured Associate Professor

Myrna’s research emphasis lies in oncology and palliative care, which has expanded to include nursing workforce due to nurses’ integral role in healthcare. Her research outcomes have been translated into published manuscripts and have contributed to the establishment of two NGOs dedicated to serving Lebanese breast cancer patients. Additionally, she holds memberships in two national committees and a hospital committee at AUBMC, all related to her areas of expertise.

Throughout her career, she has held various academic and administrative positions, starting in 1990. Notably, she served as the Chair of the Curriculum Committee at AUBSON from 2008 to 2011 and as the Founding Assistant Dean at LAU from 2011 to 2022. In her role as Founding Assistant Dean, she successfully elevated a new school to national prominence in record time and played a crucial role in achieving CCNE accreditation twice.

During her tenure as President of the Order of Nurses in Lebanon from 2018 to 2021, she navigated challenging circumstances to elevate the organization’s national influence. She spearheaded initiatives resulting in the issuance of two decrees concerning the continuing education for nurses and the regularization of the nursing profession. Additionally, as President of the Arab Nurses and Midwives at the Arab Board, she collaborates with colleagues from across Arab countries to advance the nursing profession regionally.

She actively contributes to the field through her involvement in the International Society of Nurses in Cancer Care (ISNCC) conference management committee and the Global Power of Oncology Nursing (GPON) steering and coordination committees.

Dr C S Pramesh

Dr C S Pramesh

Dr C S Pramesh is the Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre, Mumbai. He has been serving on the UICC Board of Directors since 2020. He is the convener for the National Cancer Grid, a large network of 300+ cancer centres in India (https://tmc.gov.in/ncg). The mandate of the National Cancer Grid is to provide uniform standards of cancer care across the country. Pramesh is highly committed to efforts towards reducing inequities in cancer care and making cancer treatment accessible to all geographic regions and strata of society. He is a recipient of the prestigious Rachel Pearline global cancer research humanitarian award from the National Cancer Institute, USA.

He is a visiting professor at the Division of Cancer Studies, King’s College London, the Institute of Cancer Policy, King’s Health Partners, London, and the National Cancer Center Graduate School of Cancer Science and Policy, Korea. He serves on the advisory boards of several national and international research organizations and granting agencies. including ASCO, ESMO and the UICC.

His clinical interests include the management of esophageal and lung cancers and minimally invasive surgery. He is the Principal Investigator in several investigator-initiated research studies including randomized trials on cancer screening, surgical techniques, neoadjuvant and adjuvant treatment of thoracic cancers. His research interests include health services research, value-based care, addressing barriers to access, and cancer policy. He has more than 300 peer-reviewed journal articles, abstracts and book chapters on various topics including thoracic oncology, clinical research methods, translational research, cancer policy and health disparities.

Prof Pramesh has strong interests in clinical trial designs, surgical trials, comparative effectiveness research, promoting collaborative research, health services research, and cancer policy. He is a Post Graduate Diplomate in Clinical Trials from the London School of Hygiene and Tropical Medicine, University of London. He is keen on promoting training in clinical research methods and conducts several courses on clinical research methodology, biostatistics and scientific writing.

.

 

Vania C. Wisdom, PhD

Vania C. Wisdom, PhD

Vania Wisdom is a Senior Executive Editor at The Lancet, where she oversees the Fast-Track peer-review service and is involved in the overall strategy of the journal. Dr Wisdom editorial work includes a broad range of health topics, but her main area of interest is cancer. She oversees the oncology strategy for the journal as the Oncology Ambassador. 

As an Oncology Ambassador at The Lancet Dr. Wisdom believes that stimulating conversation and facilitating information exchange, amongst all the stakeholders in the Oncology community, is a strong tool to transform the knowledge created, into social action. Dr Wisdom has been the editorial lead for several Lancet Commissions including the Lancet Commission on Women, Power and Cancer launched in 2023, the Lancet Commission on Prostate Cancer launched in 2024 and the ongoing  Lancet Commission on Cancer and Healthcare Systems.

Before joining The Lancet, she had a strong academic and award-winning scientific career as a researcher in oncology, in the UK, Germany and Portugal. She is now based in London, UK.

.

 

Dr Mark P. Lythgoe

Dr Mark P. Lythgoe

Mark P. Lythgoe is an academic clinical fellow in Medical Oncology and pharmacist.  After studying Pharmacy at Aston University, Mark went on to graduate with a duel distinction in Medicine from King’s College London. After completion of junior doctor posts in west London, he is now undertaking specialist academic training in Medical Oncology. 

He has published over >100 papers in peer-reviewed journals including the Lancet, Lancet Oncology, the BMJ, JAMA Oncology and Nature Reviews Clinical Oncology.  He has also presented his work internationally at ASCO, ESMO, ASCO-GU, ASCO-GI, ESMO-Breast and SITC. Mark has been awarded ASCO merit awards and the Sylvia Lawler prize on 2 separate occasions.  

Mark has an interest in healthcare and regulatory policy, specifically around the integration of precision oncology and the evolving access to essential cancer medicines.  Mark hopes to share his knowledge on the inequalities associated with access to essential cancer medicines at  London Global Cancer Week.

.

 

Jenna Bhimani

Jenna Bhimani

Jenna Bhimani is an academic clinical oncology fellow in London. She also works as a health systems researcher in cancer epidemiology with a focus on disparities in health services delivery for women undergoing treatment for cancer.

In 2021, she completed a Masters in Public Health at Columbia University and subsequently pursued post-doctoral research in cancer epidemiology at Memorial Sloan Kettering Cancer Center. At MSK, she published several papers and presented at global cancer conferences on disparities in breast cancer treatment in the USA.

Jenna is a co-author on the 2023 Lancet Commission on Women and Cancer, which applies an intersectional feminist approach to investigate, expose, and challenge the current imbalance of power in relation to cancer. 

Outside of clinical medicine and academia, she has worked as a consultant for several international organisations on a range of global health issues, including pandemic preparedness and improving access to universal health coverage. She is an avid runner and recently completed the 2024 New York City Marathon.

Neil Ranasinghe

Neil Ranasinghe

Neil Ranasinghe (BA) is the parent of a child who was diagnosed with leukaemia when she was 4 and has been in remission for over 15 years. Since then he has been involved with multiple cancer organisations, contributing his expertise as a Technical Author and his leadership capabilities. Outside his voluntary activities, Neil is a Lead Technical Author at the London Stock Exchange Group.

Neil is a co-founder of the Paediatric Oncology Reference Team (PORT). PORT is a group of parents that review paediatric oncology clinical trial documentation for parents and patients. PORT has reviewed documentation for over 30 clinical trials and advised on research and trials.

For the International Society of Paediatric Oncology (SIOP) Neil is involved with the SIOP Global Mapping programme, and the Global Health Network that helps and advocates for children with cancer in low or middle-income countries (LMIC).

Neil is passionate about helping clinicians in LMIC, and guiding clinicians from the UK into mutually beneficial global partnerships.

.

 

Our Management Team

Emma-Jayne King - Project Manager

Emma-Jayne King - Project Manager

Emma-Jayne is a consultant specialising in business to business (B2B) corporate events.

As the Project Manager for London Global Cancer Week for the past 4 years, Emma-Jayne is the ‘eyes and ears’ of the Week, supporting all contributing Hosts with event planning, preparation and delivery.

Emma-Jayne started her career in corporate events in 2012 as a conference producer for an award-winning B2B digital media and events business, specialising in financial services and technology. In 2013 she relocated to Hong Kong where she spent four years producing events in global banking and digital marketing, before moving to Dubai, UAE in 2017 to pick up a portfolio of events within the shared services and outsourcing sector.

Upon her return to the UK, Emma-Jayne spent 18-months heading up retail events at a community-based events start-up, before making the decision to go-it-alone in November 2019 – just before the global pandemic hit!

As a sole trader, Emma-Jayne has truly ‘found her groove’ and enjoys working with a number of regular clients across a plethora of sectors. She loves working with the London Global Cancer Week team and considers it a privilege to be able to contribute to such a worthwhile and important cause.

She lives in Hitchin, Hertfordshire with her boyfriend and their cat-son, Ralphy.

 

Heather EE - Marketing Manager & In-House Graphic Designer

Heather EE - Marketing Manager & In-House Graphic Designer

As the Marketing Manager specialising in social media and the in-house Graphic Designer at London Global Cancer Week, Heather brings more than a job title to the table. With a tenure spanning 3 enriching years, she has been at the forefront of boosting the organisation’s mission through her unique social media coverage and masterclasses. These sessions empower hosts to amplify their events, aiming to create a global impact and aid change to those in need around the world.

Prior to joining London Global Cancer Week, Heather flexed her marketing muscles as a freelance consultant for 7 years, working across multiple industry sectors. Her wealth of experience has not only helped her become a linchpin in her current role but also serves her well in her permanent residence with an IT global distribution firm.

While her professional skills across the marketing spectrum are manifold, what truly sets Heather apart is her effervescent personality. A self-proclaimed “happy-go-lucky” individual, she finds joy in dancing, fostering community spirit, and staying ahead of the latest trends to create “positive vibe” content for social media.

For Heather, working with London Global Cancer Week is more than a job—it’s a fulfilling endeavor that allows her to contribute to a cause larger than herself. By combining her skill set and passion, she plays a crucial role in promoting equity in global health.

 

Simon Middleton - Website Manager/Front End Developer

Simon Middleton - Website Manager/Front End Developer

Simon is a Senior Front End web developer who predominantly builds websites for NHS Trusts and Housing associations and has been with LGCW since its inception.  As a largely self taught developer, the LGCW site has evolved in tandem with his own expertise and he takes great pleasure in managing and upgrading the site each year whilst working alongside a tight-nit group of colleagues and friends.

When he’s not deep in code, Simon can often be found writing and recording music with his band “Fortnight in Florida” or unwinding on a walk in the Surrey Hills with his Daughter, Luna and King Charles Cavalier, Dandelion.

 

Support

London Global Cancer Week has the support of Cancer Research UK, Chatham House, the Church of England, the International Network for Cancer Treatment and Research, Royal Society of Medicine, the Tropical Health Education Trust, and World Child Cancer.